Clinical Trials Directory

Trials / Terminated

TerminatedNCT05014698

IDEntification of New Predisposition Genes in Differentiated THYroid Cancer

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
34 (actual)
Sponsor
Nantes University Hospital · Academic / Other
Sex
All
Age
8 Years
Healthy volunteers
Accepted

Summary

The purpose of this research is to find new predisposition genes for differentiated thyroid cancer (DTC).

Detailed description

The purpose of this research is to find new predisposition genes for differentiated thyroid cancer (DTC). Therefore, in the absence of a BAP1 and DICER1 abnormality, we offer to sequence your whole genome (WGS) or partial genome (genotyping) for a previously unknown genetic abnormality. Furthermore, the discovery of new genes would be a major medical advance that could contribute to the identification of new therapeutic targets. This research will be conducted at the University Hospital of Nantes and the Hospital of Vendée and 95 people should participate.

Conditions

Interventions

TypeNameDescription
GENETICWGSWhole Genome sequencing

Timeline

Start date
2022-02-23
Primary completion
2026-01-13
Completion
2026-01-13
First posted
2021-08-20
Last updated
2026-01-28

Locations

2 sites across 1 country: France

Source: ClinicalTrials.gov record NCT05014698. Inclusion in this directory is not an endorsement.